Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for health insurers and ...

While West Virginia's employee health insurance program covers drugs like Ozempic for people with type 2 diabetes, officials ...

Clalit Health Services announced on Monday that it will subsidize the long-standing Wegovy injection by 50%. This comes after both Maccabi and Meuhedet Health Services announced the same subsidy ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

According to key opinion leaders, positive SURMOUNT-5 results, alongside Lilly’s business strategy, means Zepbound is set to ...

How GLP-1 therapies could help build a healthier, more productive workforce—and what that would mean for how we live together ...

Lory Osborn says the Wegovy she was prescribed 15 months ... adopted similar stances for the drugs, which can cost patients more than $1,000 monthly out-of-pocket. In 2024, Blue Cross Blue Shield ...

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic.

which is in the process of convincing some governments to pay for Wegovy for the most overweight. The monthly cost for patients will be 7,504 Japanese yen ($50.15) for a 0.25-milligram starter ...